|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Kruijf EM, van Nes JG, van de Velde CJ,
Putter H, Smit VT, Liefers GJ, Kuppen PJ, Tollenaar RA and Mesker
WE: Tumor-stroma ratio in the primary tumor is a prognostic factor
in early breast cancer patients, especially in triple-negative
carcinoma patients. Breast Cancer Res Treat. 125:687–696. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mesker WE, Junggeburt JM, Szuhai K, de
Heer P, Morreau H, Tanke HJ and Tollenaar RA: The carcinoma-stromal
ratio of colon carcinoma is an independent factor for survival
compared to lymph node status and tumor stage. Cell Oncol.
29:387–398. 2007.PubMed/NCBI
|
|
6
|
Dunér S, Lindman Lopatko J, Ansari D,
Gundewar C and Andersson R: Pancreatic cancer: The role of
pancreatic stellate cells in tumor progression. Pancreatology.
10:673–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C,
Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led
collective invasion of carcinoma cells with differing roles for
RhoGTPases in leading and following cells. Nat Cell Biol.
9:1392–1400. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin RZ and Chang HY: Recent advances in
three-dimensional multicellular spheroid culture for biomedical
research. Biotechnol J. 3:1172–1184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karamitopoulou E, Zlobec I, Born D,
Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B and Lugli
A: Tumour budding is a strong and independent prognostic factor in
pancreatic cancer. Eur J Cancer. 49:1032–1039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ueno H, Price AB, Wilkinson KH, Jass JR,
Mochizuki H and Talbot IC: A new prognostic staging system for
rectal cancer. Ann Surg. 240:832–839. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prall F: Tumour budding in colorectal
carcinoma. Histopathology. 50:151–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koike M, Kodera Y, Itoh Y, Nakayama G,
Fujiwara M, Hamajima N and Nakao A: Multivariate analysis of the
pathologic features of esophageal squamous cell cancer: Tumor
budding is a significant independent prognostic factor. Ann Surg
Oncol. 15:1977–1982. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Landau MS, Hastings SM, Foxwell TJ,
Luketich JD, Nason KS and Davison JM: Tumor budding is associated
with an increased risk of lymph node metastasis and poor prognosis
in superficial esophageal adenocarcinoma. Mod Pathol. 27:1578–1589.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zlobec I and Lugli A: Epithelial
mesenchymal transition and tumor budding in aggressive colorectal
cancer: Tumor budding as oncotarget. Oncotarget. 1:651–661. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karamitopoulou E: Role of
epithelial-mesenchymal transition in pancreatic ductal
adenocarcinoma: Is tumor budding the missing link? Front Oncol.
3:2212013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arlt A, Müerköster SS and Schäfer H:
Targeting apoptosis pathways in pancreatic cancer. Cancer Lett.
332:346–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leers MP, Kölgen W, Björklund V, Bergman
T, Tribbick G, Persson B, Björklund P, Ramaekers FC, Björklund B,
Nap M, et al: Immunocytochemical detection and mapping of a
cytokeratin 18 neo-epitope exposed during early apoptosis. J
Pathol. 187:567–572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tod J, Jenei V, Thomas G and Fine D:
Tumor-stromal interactions in pancreatic cancer. Pancreatology.
13:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feig C, Gopinathan A, Neesse A, Chan DS,
Cook N and Tuveson DA: The pancreas cancer microenvironment. Clin
Cancer Res. 18:4266–4276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen K, Ji L, Gong C, Ma Y, Yang L, Fan Y,
Hou M and Wang Z: Notoginsenoside Ft1 promotes angiogenesis via
HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and
Raf/MEK/ERK signaling pathways. Biochem Pharmacol. 84:784–792.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tan CY and Hagen T: Post-translational
regulation of mTOR complex 1 in hypoxia and reoxygenation. Cell
Signal. 25:1235–1244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arlt A, Gehrz A, Müerköster S, Vorndamm J,
Kruse ML, Fölsch UR and Schäfer H: Role of NF-kappaB and Akt/PI3K
in the resistance of pancreatic carcinoma cell lines against
gemcitabine-induced cell death. Oncogene. 22:3243–3251. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamacher R, Schmid RM, Saur D and
Schneider G: Apoptotic pathways in pancreatic ductal
adenocarcinoma. Mol Cancer. 7:642008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chaux A, Munari E, Cubilla AL, Hicks J,
Lecksell K, Burnett AL and Netto GJ: Immunohistochemical expression
of the mammalian target of rapamycin pathway in penile squamous
cell carcinomas: A tissue microarray study of 112 cases.
Histopathology. 64:863–871. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gil Z, Cavel O, Kelly K, Brader P, Rein A,
Gao SP, Carlson DL, Shah JP, Fong Y and Wong RJ: Paracrine
regulation of pancreatic cancer cell invasion by peripheral nerves.
J Natl Cancer Inst. 102:107–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
